“Effect of Spesolimab on Achieving Sustained Disease Remission in Patients with Generalized Pustular Psoriasis: Results from the Effisayil 2 Study”, J of Skin, vol. 7, no. 6, p. s247, Nov. 2023, doi: 10.25251/skin.7.supp.247.